期刊
SEMINARS IN INTERVENTIONAL RADIOLOGY
卷 38, 期 4, 页码 466-471出版社
THIEME MEDICAL PUBL INC
DOI: 10.1055/s-0041-1735571
关键词
radioembolization; Y90; dosimetry; liver cancer; interventional radiology
The dosimetry of radioembolization for hepatocellular carcinoma has evolved into personalized and ablative applications, leading to paradigm shifts in safety and efficacy. Treatment approaches have shifted from conventional to tailored and definitive therapy.
Radioembolization dosimetry for the treatment of hepatocellular carcinoma has evolved alongside our understanding of best practice for this therapy. At the core of advances in dosimetry are personalized and ablative applications of radioembolization, which have generated paradigm shifts in both safety and efficacy. This review provides a summary of fundamental radioembolization dosimetry concepts and narrates how our approach to treating patients has shifted from conventional to tailored and definitive therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据